Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.

Literature DB >> 6273208

Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.

S Agurell, S Carlsson, J E Lindgren, A Ohlsson, H Gillespie, L Hollister.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1981 PMID： 6273208 DOI： 10.1007/bf02085029

Source DB: PubMed Journal: Experientia ISSN： 0014-4754

× No keyword cloud information.

7 in total

1. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.

Authors: I G Karniol; I Shirakawa; N Kasinski; A Pfeferman; E A Carlini
Journal: Eur J Pharmacol Date: 1974-09 Impact factor: 4.432

2. Cannabidiol and cannabinol in man.

Authors: L E Hollister
Journal: Experientia Date: 1973

3. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.

Authors: M Perez-Reyes; M C Timmons; K H Davis; E M Wall
Journal: Experientia Date: 1973-11-15

4. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.

Authors: L E Hollister; H Gillespie
Journal: Clin Pharmacol Ther Date: 1975-07 Impact factor: 6.875

Review 5. Clinical studies on the interaction of psychopharmacologic agents with marihuana.

Authors: L Lemberger; B Dalton; R Martz; B Rodda; R Forney
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

6. Cannabidiol and delta 9-tetrahydrocannabinol metabolism. In vitro comparison of mouse and rat liver crude microsome preparations.

Authors: H K Borys; R Karler
Journal: Biochem Pharmacol Date: 1979-05-01 Impact factor: 5.858

7. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Authors: A Ohlsson; J E Lindgren; A Wahlen; S Agurell; L E Hollister; H K Gillespie
Journal: Clin Pharmacol Ther Date: 1980-09 Impact factor: 6.875

7 in total

35 in total

1. THC and CBD blood and brain concentrations following daily administration to adolescent primates.

Authors: S L Withey; J Bergman; M A Huestis; S R George; B K Madras
Journal: Drug Alcohol Depend Date: 2020-06-18 Impact factor: 4.492

Review 2. Human cannabinoid pharmacokinetics.

Authors: Marilyn A Huestis
Journal: Chem Biodivers Date: 2007-08 Impact factor: 2.408

Review 3. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors: Gail D Anderson; Lingtak-Neander Chan
Journal: Clin Pharmacokinet Date: 2016-11 Impact factor: 6.447

4. Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.

Authors: Daniel J Liput; Dana C Hammell; Audra L Stinchcomb; Kimberly Nixon
Journal: Pharmacol Biochem Behav Date: 2013-09-05 Impact factor: 3.533

5. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans.

Authors: Alex F Manini; Georgia Yiannoulos; Mateus M Bergamaschi; Stephanie Hernandez; Ruben Olmedo; Allan J Barnes; Gary Winkel; Rajita Sinha; Didier Jutras-Aswad; Marilyn A Huestis; Yasmin L Hurd
Journal: J Addict Med Date: 2015 May-Jun Impact factor: 3.702